{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:22Z","timestamp":1793633482442,"version":"4.5.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012633","name":"Korea Innovation Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omtn.2026.103112","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:02:54Z","timestamp":1790175774000},"page":"103112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural insights into an aptainhibitor of the SARS-CoV-2 E protein using molecular docking, molecular dynamics, and biophysical analyses"],"prefix":"10.1016","volume":"37","author":[{"given":"Miyssa Imam","family":"Abdelmageed Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Ri","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Hwan","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiho","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-2284","authenticated-orcid":false,"given":"Ji-Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103112_bib1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMe2001126","article-title":"Another Decade, Another Coronavirus","volume":"382","author":"Perlman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103112_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coviro.2020.05.010","article-title":"The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health","volume":"40","author":"Sheahan","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omtn.2026.103112_bib3","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.ymthe.2024.03.029","article-title":"In vitro and in vivo validation of the antiviral effect of hCypA against SARS-CoV-2 via binding to the RBD of spike protein","volume":"32","author":"Shin","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103112_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012328","article-title":"Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis","volume":"8","author":"Relan","year":"2023","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.omtn.2026.103112_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/vaccines11020243","article-title":"Synergistic Immunity and Protection in Mice by Co-Immunization with DNA Vaccines Encoding the Spike Protein and Other Structural Proteins of SARS-CoV-2","volume":"11","author":"Chen","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.omtn.2026.103112_bib6","article-title":"Mutational insights into the envelope protein of SARS-CoV-2","volume":"22","author":"Rahman","year":"2021","journal-title":"Gene Rep."},{"key":"10.1016\/j.omtn.2026.103112_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.virol.2012.07.005","article-title":"Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids","volume":"432","author":"Verdi\u00e1-B\u00e1guena","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2026.103112_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000511","article-title":"Structure and inhibition of the SARS coronavirus envelope protein ion channel","volume":"5","author":"Pervushin","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2026.103112_bib9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.bbamem.2018.02.017","article-title":"Structural model of the SARS coronavirus E channel in LMPG micelles","volume":"1860","author":"Surya","year":"2018","journal-title":"Biochim. Biophys. Acta. Biomembr."},{"key":"10.1016\/j.omtn.2026.103112_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114242","article-title":"SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development","volume":"159","author":"Zhou","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2026.103112_bib11","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016175","article-title":"The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles","volume":"296","author":"Boson","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.103112_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2026.103112_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11262-009-0341-6","article-title":"Expression and membrane integration of SARS-CoV E protein and its interaction with M protein","volume":"38","author":"Chen","year":"2009","journal-title":"Virus Genes"},{"key":"10.1016\/j.omtn.2026.103112_bib14","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.7150\/ijbs.64977","article-title":"The intraviral protein-protein interaction of SARS-CoV-2 reveals the key role of N protein in virus-like particle assembly","volume":"17","author":"Chen","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.omtn.2026.103112_bib15","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1111\/febs.15881","article-title":"Host PDZ-containing proteins targeted by SARS-CoV-2","volume":"288","author":"Caillet-Saguy","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.omtn.2026.103112_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004320","article-title":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis","volume":"10","author":"Jimenez-Guarde\u00f1o","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2026.103112_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02325-17","article-title":"Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis","volume":"9","author":"Casta\u00f1o-Rodriguez","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.omtn.2026.103112_bib18","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41594-020-00536-8","article-title":"Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers","volume":"27","author":"Mandala","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103112_bib19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/JVI.01467-06","article-title":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo","volume":"81","author":"DeDiego","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.103112_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004077","article-title":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis","volume":"10","author":"Nieto-Torres","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2026.103112_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41421-023-00575-7","article-title":"Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.omtn.2026.103112_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106185","article-title":"Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2","volume":"145","author":"Breitinger","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.omtn.2026.103112_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12985-023-02095-y","article-title":"Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2","volume":"20","author":"Breitinger","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2026.103112_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011328","article-title":"Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2","volume":"19","author":"Ewart","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2026.103112_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbrc.2020.05.206","article-title":"SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine","volume":"530","author":"Singh Tomar","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2026.103112_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.cr.7290286","article-title":"Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2026.103112_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281281","article-title":"Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection","volume":"18","author":"Qiao","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.103112_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002522","article-title":"Developing inhibitory peptides against SARS-CoV-2 envelope protein","volume":"22","author":"Bekdash","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtn.2026.103112_bib29","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1128\/AAC.00542-08","article-title":"Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus","volume":"52","author":"Dai","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2026.103112_bib30","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","article-title":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses","volume":"32","author":"Li","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.omtn.2026.103112_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12951-022-01391-z","article-title":"Structure based innovative approach to analyze aptaprobe\u2013GPC3 complexes in hepatocellular carcinoma","volume":"20","author":"Shin","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2026.103112_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202300584","article-title":"Aptamers: Promising Reagents in Biomedicine Application","volume":"8","author":"Zhou","year":"2024","journal-title":"Advanced Biology"},{"key":"10.1016\/j.omtn.2026.103112_bib33","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1039\/C7NR01827D","article-title":"Aptabody\u2013aptatope interactions in aptablotting assays","volume":"9","author":"Sekhon","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.omtn.2026.103112_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1543","article-title":"Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles","volume":"11","author":"Sivakumar","year":"2019","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2026.103112_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2017.0680","article-title":"Effect of chemical modifications on aptamer stability in serum","volume":"27","author":"Kratschmer","year":"2017","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtn.2026.103112_bib36","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.2174\/092986711797189565","article-title":"Improving the stability of aptamers by chemical modification","volume":"18","author":"E Wang","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.omtn.2026.103112_bib37","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/s41467-023-37002-0","article-title":"An aptamer-based depot system for sustained release of small molecule therapeutics","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103112_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jama.2020.27124","article-title":"Genetic Variants of SARS-CoV-2-What Do They Mean?","volume":"325","author":"Lauring","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.omtn.2026.103112_bib39","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S1473-3099(25)00308-1","article-title":"Antigenic and virological characteristics of SARS-CoV-2 variants BA. 3.2, XFG, and NB. 1.8. 1","volume":"7","author":"Guo","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omtn.2026.103112_bib40","article-title":"Antibody evasion and receptor binding of SARS-CoV-2 LP. 8.1. 1, NB. 1.8. 1, XFG, and related subvariants","author":"Mellis","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2026.103112_bib41","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pro.4075","article-title":"Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors","volume":"30","author":"Cao","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.omtn.2026.103112_bib42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2026.103112_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jbiosc.2011.08.014","article-title":"Novel system for detecting SARS coronavirus nucleocapsid protein using an ssDNA aptamer","volume":"112","author":"Cho","year":"2011","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.omtn.2026.103112_bib46","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1039\/b906788d","article-title":"RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein","volume":"134","author":"Ahn","year":"2009","journal-title":"Analyst"},{"key":"10.1016\/j.omtn.2026.103112_bib47","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/cbic.200800491","article-title":"Differential Inhibitory Activities and Stabilisation of DNA Aptamers against the SARS Coronavirus Helicase","volume":"9","author":"Shum","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.omtn.2026.103112_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2021.131060","article-title":"Fabrication of MERS-nanovesicle biosensor composed of multi-functional DNA aptamer\/graphene-MoS2 nanocomposite based on electrochemical and surface-enhanced Raman spectroscopy","volume":"352","author":"Kim","year":"2022","journal-title":"Sens. Actuators. B Chem."},{"key":"10.1016\/j.omtn.2026.103112_bib49","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1021\/acs.analchem.0c01394","article-title":"Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein","volume":"92","author":"Song","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.omtn.2026.103112_bib50","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1002\/anie.202100345","article-title":"Neutralizing Aptamers Block S\/RBD-ACE2 Interactions and Prevent Host Cell Infection","volume":"60","author":"Liu","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omtn.2026.103112_bib51","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1002\/anie.202100225","article-title":"Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection","volume":"60","author":"Sun","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omtn.2026.103112_bib52","doi-asserted-by":"crossref","first-page":"21211","DOI":"10.1002\/anie.202107730","article-title":"Discovery and Characterization of Spike N-Terminal Domain-Binding Aptamers for Rapid SARS-CoV-2 Detection","volume":"60","author":"Kacherovsky","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omtn.2026.103112_bib53","doi-asserted-by":"crossref","first-page":"16646","DOI":"10.1021\/acs.analchem.1c04156","article-title":"Aptamer-Functionalized Nanochannels for One-Step Detection of SARS-CoV-2 in Samples from COVID-19 Patients","volume":"93","author":"Shi","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.omtn.2026.103112_bib54","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1093\/nar\/gkab574","article-title":"Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library","volume":"49","author":"Li","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103112_bib55","article-title":"A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS-CoV-2 Variants of Concern","volume":"28","author":"Zhang","year":"2022","journal-title":"Chemistry (Easton)."},{"key":"10.1016\/j.omtn.2026.103112_bib56","doi-asserted-by":"crossref","first-page":"10235","DOI":"10.1039\/D0CC03993D","article-title":"Discovery of sandwich type COVID-19 nucleocapsid protein DNA aptamers","volume":"56","author":"Zhang","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.omtn.2026.103112_bib61","doi-asserted-by":"crossref","first-page":"13840","DOI":"10.1021\/la9019475","article-title":"Gold nanoparticles: past, present, and future","volume":"25","author":"Sardar","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.omtn.2026.103112_bib62","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.2147\/IJN.S476995","article-title":"Exosomes induce crosstalk between multiple types of cells and cardiac fibroblasts: therapeutic potential for remodeling after myocardial infarction","volume":"19","author":"Feng","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.omtn.2026.103112_bib63","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA11: Molecular Evolutionary Genetics Analysis Version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.omtn.2026.103112_bib64","doi-asserted-by":"crossref","first-page":"D387","DOI":"10.1093\/nar\/gkn750","article-title":"The SWISS-MODEL Repository and associated resources","volume":"37","author":"Kiefer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103112_bib65","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802608786786624","article-title":"Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery","volume":"8","author":"Vilar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.omtn.2026.103112_bib66","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103112_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4939-6433-8_13","article-title":"Automated RNA 3D structure prediction with RNAComposer","volume":"1490","author":"Biesiada","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103112_bib68","series-title":"LigPlot+: Multiple Ligand\u2013Protein Interaction Diagrams for Drug Discovery","author":"Laskowski","year":"2011"},{"key":"10.1016\/j.omtn.2026.103112_bib69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:16:47Z","timestamp":1793632607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2162253126002830"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103112","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural insights into an aptainhibitor of the SARS-CoV-2 E protein using molecular docking, molecular dynamics, and biophysical analyses","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103112"}}